User profiles for Christian Steidl
 | Christian SteidlProfessor, Department of Pathology and Laboratory Medicine, University of British Columbia Verified email at bccancer.bc.ca Cited by 23066 |
[HTML][HTML] Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
Background Despite advances in treatments for Hodgkin's lymphoma, about 20% of
patients still die from progressive disease. Current prognostic models predict the outcome of …
patients still die from progressive disease. Current prognostic models predict the outcome of …
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
…, A Delaney, K Gelmon, R Guliany, J Senz, C Steidl… - Nature, 2009 - nature.com
Recent advances in next generation sequencing 1 , 2 , 3 , 4 have made it possible to
precisely characterize all somatic coding mutations that occur during the development and …
precisely characterize all somatic coding mutations that occur during the development and …
[HTML][HTML] Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and …
Purpose Diffuse large B-cell lymphoma (DLBCL) is curable in 60% of patients treated with
rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). MYC …
rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). MYC …
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
…, P Valent, C Fonatsch, C Steidl - Blood, The Journal …, 2007 - ashpublications.org
We have generated a large, unique database that includes morphologic, clinical, cytogenetic,
and follow-up data from 2124 patients with myelodysplastic syndromes (MDSs) at 4 …
and follow-up data from 2124 patients with myelodysplastic syndromes (MDSs) at 4 …
[HTML][HTML] New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived …
…, ML Slovak, K Ohyashiki, C Steidl… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Purpose The karyotype is a strong independent prognostic factor in myelodysplastic syndromes
(MDS). Since the implementation of the International Prognostic Scoring System (IPSS) …
(MDS). Since the implementation of the International Prognostic Scoring System (IPSS) …
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Chromosomal translocations are critically involved in the molecular pathogenesis of B-cell
lymphomas, and highly recurrent and specific rearrangements have defined distinct …
lymphomas, and highly recurrent and specific rearrangements have defined distinct …
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
BCL2 and MYC are oncogenes commonly deregulated in lymphomas. Concurrent BCL2
and MYC translocations (BCL2 + /MYC + ) were identified in 54 samples by karyotype and/or …
and MYC translocations (BCL2 + /MYC + ) were identified in 54 samples by karyotype and/or …
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing
Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous cancer composed of
at least 2 molecular subtypes that differ in gene expression and distribution of mutations. …
at least 2 molecular subtypes that differ in gene expression and distribution of mutations. …
Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment
C Steidl, JM Connors, RD Gascoyne - Journal of Clinical Oncology, 2011 - ascopubs.org
Hodgkin's lymphoma (HL) represents the most common subtype of malignant lymphoma in
young people in the Western world. Most patients can be cured with modern treatment …
young people in the Western world. Most patients can be cured with modern treatment …
[HTML][HTML] Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue …
Purpose To evaluate the prognostic impact of cell-of-origin (COO) subgroups, assigned
using the recently described gene expression–based Lymph2Cx assay in comparison with …
using the recently described gene expression–based Lymph2Cx assay in comparison with …
